- Nuvo Pharmaceuticals press release ( OTCQX:MRVFF ): Q3 Revenue of $18.1M (+6.5% Y/Y).
- Net income of $0.4 million
For further details see:
Nuvo Pharmaceuticals reports Q3 resultshome / stock / mrvff / mrvff news
For further details see:
Nuvo Pharmaceuticals reports Q3 resultsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Nuvo Pharmaceuticals Inc Company Name:
MRVFF Stock Symbol:
Market:
Nuvo Pharmaceuticals Inc (MRVFF) is expected to report for Q4 2022
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that it has obtained a final court order from the Ontario Superior Court of Justice (Commercial List) approving its previously announ...
Nuvo Pharmaceuticals Inc. d/b/a Miravo Healthcare (TSX:MRV; OTCQX:MRVFF) (“ Miravo ” or the “ Company ”) is pleased to announce that, at today’s special meeting of shareholders (the “ Meeting ”), its shareholders (“ Shareho...